Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background: Radical hysterectomy is an important therapy for early cervical cancer. Disfunction of urinary dynamics is the most common postoperative adverse effects, which had negative impact on patients' quality of life. Nerve sparing radical hysterectomy (NSRH) could reserve inferior hypogastric plexus (IHP) innervating bladder, hence improving postoperative urinary dynamics. Furthermore impact of different energy instruments on urinary dynamic isn't clear.
Objectives: This study is to compare urinary dynamics before and after NSRH, and to analyze the difference between BiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) and water jet (ERBEJET®2) about the effects of dissecting IHP.
Study population: Cervical cancer of FIGO IB stage, among which 120 cases are enrolled to randomly allocated to BiClamp group or water jet group.
Intervention: Patients accept NSRH which all will be accomplished by Professor Ming Wu.
Methods: All surgical patients are accessed via urinary dynamics before and four months after NSRH. On the 14th day after surgeries, urinary catheter will be removed and residual urine volume (RUV) will be measured. For patients of RUV > 100 ml, urinary catheter will be replaced.
Primary study endpoint: the successful rate of removing urinary catheter on the 14th day after NSRH.
Secondary study endpoint: urinary dynamics four months after NSRH.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BiClamp group | Placebo Comparator | BiClamp forcep (BiClampĀ® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus |
|
| water jet group | Active Comparator | water jet (ERBEJET®2, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BiClamp group | Procedure | electric energy |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| successful rate of removing urinary catheter | successful rate (%) of removing urinary catheter assessed by residual urine volume less than 100 ml | 14th day after nerve-sparing radical hysterectomy |
| Measure | Description | Time Frame |
|---|---|---|
| urinary dynamics parameters determined by urodynamics apparatus: bladder capacity and sensation | bladder capacity and sensation in ml | four months after nerve-sparing radical hysterectomy |
| urinary dynamics parameters determined by urodynamics apparatus: residual urine volume |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wu Ming, MD | Peking Union Medical College Hospital | Principal Investigator |
Not provided
IPD will be shared with authorised researchers via online database.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| D016055 | Urinary Retention |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| water jet group | Procedure | water jet energy |
|
|
residual urine volume in ml |
| four months after nerve-sparing radical hysterectomy |
| urinary dynamics parameters determined by urodynamics apparatus: urine flow rate | urine flow rate in ml/s | four months after nerve-sparing radical hysterectomy |
| urinary dynamics parameters determined by urodynamics apparatus: bladder pressure | bladder pressure in cmH2O | four months after nerve-sparing radical hysterectomy |
| urinary dynamics parameters determined by urodynamics apparatus: detrusor pressure | detrusor pressure in cmH2O | four months after nerve-sparing radical hysterectomy |
| urinary dynamics parameters determined by urodynamics apparatus: bladder compliance | bladder compliance in ml/cmH2O | four months after nerve-sparing radical hysterectomy |
| survival outcomes: ovarall survival | overall survival in months | two years after nerve-sparing radical hysterectomy |
| survival outcomes: progression-free survival | progression-free survival in months | two years after nerve-sparing radical hysterectomy |
| D009369 |
| Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052801 | Male Urogenital Diseases |